

Author: Cool W. Paul Grimer Robert J. Carter Simon R. Tillman Roger M. Davies A. Mark
Publisher: Informa Healthcare
ISSN: 1369-1643
Source: Sarcoma, Vol.2, Iss.2, 1998-06, pp. : 115-119
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Application of eupatilin in the treatment of osteosarcoma
Oncology Letters, Vol. 10, Iss. 4, 2015-01 ,pp. :




By Whelan J.S.
European Journal of Cancer, Vol. 33, Iss. 10, 1997-09 ,pp. :


A Phase II study of docetaxel for the treatment of recurrent osteosarcoma
By McTiernan Anne Whelan Jeremy S.
Sarcoma, Vol. 8, Iss. 2-3, 2004-06 ,pp. :